178 related articles for article (PubMed ID: 31658269)
1. Village-scale persistence and elimination of gambiense human African trypanosomiasis.
Davis CN; Rock KS; Mwamba Miaka E; Keeling MJ
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007838. PubMed ID: 31658269
[TBL] [Abstract][Full Text] [Related]
2. Modelling
Davis CN; Keeling MJ; Rock KS
J R Soc Interface; 2021 Oct; 18(183):20210419. PubMed ID: 34610258
[TBL] [Abstract][Full Text] [Related]
3. Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness.
Castaño MS; Aliee M; Mwamba Miaka E; Keeling MJ; Chitnis N; Rock KS
J Infect Dis; 2020 Jun; 221(Suppl 5):S539-S545. PubMed ID: 31876949
[TBL] [Abstract][Full Text] [Related]
4. Comparison of stochastic and deterministic models for gambiense sleeping sickness at different spatial scales: A health area analysis in the DRC.
Davis CN; Crump RE; Sutherland SA; Spencer SEF; Corbella A; Chansy S; Lebuki J; Miaka EM; Rock KS
PLoS Comput Biol; 2024 Apr; 20(4):e1011993. PubMed ID: 38557869
[TBL] [Abstract][Full Text] [Related]
5. Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data.
Davis CN; Castaño MS; Aliee M; Patel S; Miaka EM; Keeling MJ; Spencer SEF; Chitnis N; Rock KS
Clin Infect Dis; 2021 Jun; 72(Suppl 3):S146-S151. PubMed ID: 33905480
[TBL] [Abstract][Full Text] [Related]
6. Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target?
Selby R; Wamboga C; Erphas O; Mugenyi A; Jamonneau V; Waiswa C; Torr SJ; Lehane M
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007550. PubMed ID: 31412035
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo.
Davis CN; Rock KS; Antillón M; Miaka EM; Keeling MJ
BMC Med; 2021 Apr; 19(1):86. PubMed ID: 33794881
[TBL] [Abstract][Full Text] [Related]
8. Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo.
Aliee M; Castaño S; Davis CN; Patel S; Miaka EM; Spencer SEF; Keeling MJ; Chitnis N; Rock KS
Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):245-252. PubMed ID: 33611586
[TBL] [Abstract][Full Text] [Related]
9. Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo.
Crump RE; Huang CI; Knock ES; Spencer SEF; Brown PE; Mwamba Miaka E; Shampa C; Keeling MJ; Rock KS
PLoS Comput Biol; 2021 Jan; 17(1):e1008532. PubMed ID: 33513134
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis.
Geerts M; Van Reet N; Leyten S; Berghmans R; Rock KS; Coetzer THT; Eyssen LE; Büscher P
Clin Infect Dis; 2021 Nov; 73(9):e2477-e2483. PubMed ID: 32856049
[TBL] [Abstract][Full Text] [Related]
11. A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC.
Huang CI; Crump RE; Crowley EH; Hope A; Bessell PR; Shampa C; Mwamba Miaka E; Rock KS
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011299. PubMed ID: 37115809
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo.
Antillon M; Huang CI; Crump RE; Brown PE; Snijders R; Miaka EM; Keeling MJ; Rock KS; Tediosi F
Nat Commun; 2022 Feb; 13(1):1051. PubMed ID: 35217656
[TBL] [Abstract][Full Text] [Related]
13. Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo.
Huang CI; Crump RE; Brown PE; Spencer SEF; Miaka EM; Shampa C; Keeling MJ; Rock KS
Nat Commun; 2022 Mar; 13(1):1448. PubMed ID: 35304479
[TBL] [Abstract][Full Text] [Related]
14. Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination.
Wamboga C; Matovu E; Bessell PR; Picado A; Biéler S; Ndung'u JM
PLoS One; 2017; 12(10):e0186429. PubMed ID: 29023573
[TBL] [Abstract][Full Text] [Related]
15. Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC.
Crump RE; Huang CI; Spencer SEF; Brown PE; Shampa C; Mwamba Miaka E; Rock KS
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010599. PubMed ID: 35816487
[TBL] [Abstract][Full Text] [Related]
16. Insights from quantitative and mathematical modelling on the proposed 2030 goal for gambiense human African trypanosomiasis (gHAT).
NTD Modelling Consortium Discussion Group on Gambiense Human African Trypanosomiasis
Gates Open Res; 2019; 3():1553. PubMed ID: 32411945
[TBL] [Abstract][Full Text] [Related]
17. Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk.
Lumbala C; Simarro PP; Cecchi G; Paone M; Franco JR; Kande Betu Ku Mesu V; Makabuza J; Diarra A; Chansy S; Priotto G; Mattioli RC; Jannin JG
Int J Health Geogr; 2015 Jun; 14():20. PubMed ID: 26047813
[TBL] [Abstract][Full Text] [Related]
18. Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad.
Rock KS; Huang CI; Crump RE; Bessell PR; Brown PE; Tirados I; Solano P; Antillon M; Picado A; Mbainda S; Darnas J; Crowley EH; Torr SJ; Peka M
Infect Dis Poverty; 2022 Jan; 11(1):11. PubMed ID: 35074016
[TBL] [Abstract][Full Text] [Related]
19. Priorities for the elimination of sleeping sickness.
Welburn SC; Maudlin I
Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
[TBL] [Abstract][Full Text] [Related]
20. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
